Navigating Multiple Myeloma

Описание к видео Navigating Multiple Myeloma

Multiple myeloma is a rare cancer, but is the 2nd most common blood cancer. Because the disease is incurable, most patients with multiple myeloma will eventually relapse and require further therapy. An unmet need remains for this community.

As a leader in oncology, Novartis is committed to better understanding multiple myeloma.

© 2016 Novartis AG

Комментарии

Информация по комментариям в разработке